| Survival n = 323 | 28-day mortality n = 62 | 7-day mortality n = 43 |
---|---|---|---|
Age (years) | 67.0 ± 18.7 | 76.1 ± 12.7** | 70.7 ± 16.9 |
Sex (M/F) | 222/101 | 40/22 | 24/19 |
Temperature abnormalities, n, (%) | 80 (24.8) | 21 (33.3) | 10 (23.3) |
WBC abnormalities, n, (%) | 112 (34.7) | 24 (38.1) | 25 (58.1)** |
NE abnormalities, n, (%) | 227 (70.3) | 51 (82.3) | 36 (83.7) |
APACHE II score | 18.8 ± 6.0 | 24.1 ± 5.4*** | 24.8 ± 7.8*** |
NLCR | 11.5 ± 13.4 | 13.0 ± 11.3 | 15.0 ± 14.8 |
PCT (ng/ml) | 3.6 ± 13.8 | 4.0 ± 12.5** | 7.8 ± 15.0*** |
CRP (mg/ml) | 61.1 ± 73.1 | 87.4 ± 69.1*** | 96.6 ± 76.0** |
Blood lactate (mmol/l) | 1.5 ± 1.0 | 1.9 ± 0.9** | 2.7 ± 4.0 |
Surgery, n, (%) | 99 (30.7) | 16 (25.8) | 3 (7.1)*** |
Cardiovascular disease | 18 (5.6%) | 4 (6.5%) | 10 (23.3%)*** |
Malignancies | 29 (9.0%) | 1 (1.6%)** | 4 (9.3%) |